Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Impact of COVID-19 Vaccines on Cerebrovascular Health
An update on an ongoing trial assessing whether COVID-19 vaccines affect cerebrovascular health, with recruitment currently underway for out…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia [NA]
A University of Southern California clinical trial assessing risk screening and primary prevention of elder abuse in people living with deme…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease
This clinical trial update outlines a study to generate synthetic [18F]FDG PET images from early-phase amyloid PET scans in Alzheimer's dise…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: CUHK Brain Health Longitudinal Study
The CUHK Brain Health Longitudinal Study is an ongoing clinical trial sponsored by the Chinese University of Hong Kong, currently recruiting…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Dementia and Storytelling in Vietnam [NA]
This is a clinical trial update for a study on dementia and storytelling in Vietnam involving Alzheimer's disease. The study is currently no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) [Phase 3]
A Phase 3 clinical trial of subcutaneous GV1001 for moderate to severe Alzheimer's disease is planned, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Adapting RDAD for DS [NA]
A clinical trial update indicates the University of Kansas Medical Center is adapting the RDAD program for individuals with Down syndrome an…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Improv Music Therapy for Older Adults [NA]
This document provides a clinical trial update on Improv Music Therapy for older adults, including those with Alzheimer's disease. The study…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of benfotiamine in patients with early Alzheimer's disease, and recruitment i…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
This clinical trial update describes a retrospective observational study evaluating blood-based biomarkers for diagnosing and monitoring sev…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease [Phase 1]
A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of DNL628 in participants with early Alzheimer'…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD) [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of ION269 in participants with Down syndrome at …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function [Phase 3]
Phase 3 trial evaluating an 18F-APN-1607 PET imaging agent in subjects with Alzheimer's-related cognitive impairment and normal cognition.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Exercise to Improve Brain Health in Older African Americans [Phase 2]
A Phase 2 clinical trial sponsored by Rutgers is evaluating whether a structured exercise program can improve brain health in older African …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: TMS for Cognitive Decline in Aging and Preclinical AD [NA]
This Massachusetts General Hospital-sponsored clinical trial is evaluating transcranial magnetic stimulation (TMS) for cognitive decline in …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease [EARLY_Phase 1]
Massachusetts General Hospital is conducting an early-phase 1 trial of transcranial magnetic stimulation for Alzheimer's disease and related…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
This clinical trial update describes the development of screening measures for financial hardship in individuals with Alzheimer's disease an…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Clinical Study on Deep Cervical Lymphatic Trunk Decompression Combined With Mid-Cervical Deep Lymph Node-External Jugular Vein Anastomosis for Alzheimer's Disease Treatment [NA]
This clinical trial update outlines an ongoing study evaluating a surgical approach that combines deep cervical lymphatic trunk decompressio…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Alzheimer's Registry
This clinical trial update notes an Alzheimer's disease registry sponsored by CorEvitas, with enrollment currently by invitation.
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study [Phase 3]
Phase 3 open-label extension studies (ADVANCE-2 and ACCORD-2) evaluating long-term safety of AXS-05 in Alzheimer's-related agitation have be…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) - Improving Access to Alzheimer's Disease Diagnostics: A Pragmatic System Level Intervention
This entry documents the BioMIND trial focused on biomarkers for identifying neurodegenerative dementia, aiming to improve access to Alzheim…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD) [Phase 2]
Phase 2 clinical trial update evaluating the safety and biomarker effects of RO7269162 in participants at risk for, or in the prodromal stag…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease [Phase 4]
A Phase 4 trial comparing satisfaction with orodispersible memantine versus conventional memantine in moderate to severe Alzheimer's disease…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Donepezil Versus Non-drug Treatment in Alzheimer's Disease. [Phase 3]
A Phase 3 clinical trial is evaluating donepezil versus non-drug treatment for early-onset Alzheimer's disease. The study status is recruiti…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Longitudinal Early-onset Alzheimer's Disease Study Protocol
A longitudinal study protocol for early-onset Alzheimer's disease and related cognitive impairment is being planned, with recruitment curren…